-
-
-
-
-
-
-
Awakn Life Sciences Announces Conditional Approval of CSE Listing
-
-
-
-
-
-
-
Awakn Life Sciences Reports Strong Q2 2022 Results
-
-
-
-
-
-
-
Awakn Life SciencesAcquires Exclusive Rights to MDMA Research from Imperial College London
-
1,164,409 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

